The Current States, Challenges, Ongoing Efforts, and Future Perspectives of Pharmaceutical Excipients in Pediatric Patients in Each Country and Region

A major hurdle in pediatric formulation development is the lack of safety and toxicity data on some of the commonly used excipients. While the maximum oral safe dose for several kinds of excipients is known in the adult population, the doses in pediatric patients, including preterm neonates, are not...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Jumpei, Agrawal, Anjali, Patravale, Vandana, Pandya, Anjali, Orubu, Samuel, Zhao, Min, Andrews, Gavin P., Petit-Turcotte, Caroline, Landry, Hannah, Croker, Alysha, Nakamura, Hidefumi, Yamatani, Akimasa, Salunke, Smita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026161/
https://www.ncbi.nlm.nih.gov/pubmed/35455497
http://dx.doi.org/10.3390/children9040453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026161/
https://www.ncbi.nlm.nih.gov/pubmed/35455497
http://dx.doi.org/10.3390/children9040453

Ejemplares similares